COVID's still here. So, why isn't treatment free anymore?
For all the ways President Donald Trump botched in his response to the coronavirus pandemic — and boy howdy, was it a long list — let's give a wee bit of credit where credit is due. "The president has made it very clear," then-Vice President Mike Pence said in April 2020, "we don't want Americans to worry about the cost of getting a test or the cost of getting treatment" for COVID-19.
This week, that federal program is winding down due to Senate Republicans balking at the Biden administration's request for an additional $22.5 billion to continue the battle against COVID. That means if you're one of the 28 million Americans who are uninsured — and who for two years now could have taken at least some comfort in the fact that the White House was reimbursing providers for coronavirus-related care — you're now on the hook for associated testing and medical bills. If you also happen to be one of the 25,459 Americans to test positive for COVID-19 yesterday, that's pretty scary — not to mention, infuriatingly arbitrary.
But while "Medicare for all" tends to be treated as a tentacle of America's socialism boogeyman, Trump's (CARES) Act was essentially "Medicare for COVID," Princeton University economist Janet Currie told Quartz in April 2021. That is to say, COVID-19 became a kind of mini-experiment in what it would be like to not have the ax of medical debt hanging over your head if you needed specific-to-COVID care.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
By no stretch of the imagination was it a perfectly implemented program. Also problematic: There was no requirement to tell patients upfront that their COVID treatment would be covered, leading many uninsured would-be patients not to seek care (and in extreme cases, even die as a result). But the program's shortcomings only serve to emphasize how vital it really was: Indeed, "in the U.S., we are so accustomed to paying out of pocket for essential health care that when it is provided for free, it is a foreign concept," The Nation wrote this winter, noting that at the time, a "significant barrier to vaccination [was] that some people think they will be charged for it."
Still, there will be plenty of people who shrug off the end of the program, especially since vaccinated people are so unlikely to go to the hospital (and thus accrue crippling medical bills) for COVID. True enough, the vast majority of people who will go bankrupt due to catching COVID, or die failing to seek prohibitively expensive treatment, will likely be anti-vaxxers. But that's far from a reason not to care, or fight for the program's continuation: "We don't use the medical-care system as a way of meting out justice," Matt Wynia, a doctor and ethicist at the University of Colorado, previously explained to The Atlantic. "We don't use it to punish people for their social choices." Neither should financial punishment be meted out to those who catch a contagious disease, no matter what their beliefs.
But even more than that, the takeaway from our brief period of Medicare-for-COVID ought to be how easy it was to do once politicians decided they actually wanted it. Don't let anyone tell you universal healthcare isn't possible; we've already had a taste.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Jeva Lange was the executive editor at TheWeek.com. She formerly served as The Week's deputy editor and culture critic. She is also a contributor to Screen Slate, and her writing has appeared in The New York Daily News, The Awl, Vice, and Gothamist, among other publications. Jeva lives in New York City. Follow her on Twitter.
-
'It may not be surprising that creative work is used without permission'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
5 simple items to help make your airplane seat more comfortable
The Week Recommends Gel cushions and inflatable travel pillows make a world of difference
By Catherine Garcia, The Week US Published
-
How safe are cruise ships in storms?
The Explainer The vessels are always prepared
By Devika Rao, The Week US Published
-
Wyoming judge strikes down abortion, pill bans
Speed Read The judge said the laws — one of which was a first-in-the-nation prohibition on the use of medication to end pregnancy — violated the state's constitution
By Peter Weber, The Week US Published
-
The Pentagon faces an uncertain future with Trump
Talking Point The president-elect has nominated conservative commentator Pete Hegseth to lead the Defense Department
By Justin Klawans, The Week US Published
-
Should Sonia Sotomayor retire from the Supreme Court?
Talking Points Democrats worry about repeating the history of Ruth Bader Ginsburg
By Joel Mathis, The Week US Published
-
'Being more nuanced will not be easy for public health agencies'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
'People shouldn't have to share the road with impaired drivers'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
US election: who the billionaires are backing
The Explainer More have endorsed Kamala Harris than Donald Trump, but among the 'ultra-rich' the split is more even
By Harriet Marsden, The Week UK Published
-
The GOP is renewing its focus on the abortion pill
In the Spotlight Three Republican-led states are taking another crack at suing the FDA over the abortion pill, mifepristone
By Theara Coleman, The Week US Published
-
US election: where things stand with one week to go
The Explainer Harris' lead in the polls has been narrowing in Trump's favour, but her campaign remains 'cautiously optimistic'
By Harriet Marsden, The Week UK Published